Companies: 10,795·Total market cap: $144.5T
AREV Life Sciences Global Corp.

AREV Life Sciences Global Corp.

AREVFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$15881
P/E Ratio
52W High$0.01
52W Low$0.0005

AREV Life Sciences Global Corp. (AREVF) Revenue

Annual & quarterly revenue history · segment & region breakdown

AREVF · revenue · updated Jun 9, 2026

Core revenue metrics

AREV Life Sciences Global Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
2.20×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$4K
2 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · AREV Life Sciences Global Corp. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
AREVF revenue by year · AREVF revenue history · AREVF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income AREV Life Sciences Global Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

AREV Life Sciences Global Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from AREV Life Sciences Global Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

AREVF revenue · 4 questions

AREVF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

AREVF revenueAREVF annual revenuewhat is AREVF revenueAREVF TTM revenue

Source: FMP · AREV Life Sciences Global Corp. SEC filings · GAAP · AREV Life Sciences Global Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026